NCT01129401|CompletedPhase 1/2
Stonewall Treatment Evaluation Project
STEP
Evaluation of a Harm Reduction Treatment for Methamphetamine-Using Men Who Have Sex With Men (MSM)
Loading search results
STEP
Evaluation of a Harm Reduction Treatment for Methamphetamine-Using Men Who Have Sex With Men (MSM)
Sponsor study identifier
interventional
150
1 country
2
Study Start
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2012
Actual (reported)Study Completion
May 2014
Actual (reported)This treatment outcome evaluation of the Stonewall Project will recruit 150 participants to complete a face-to-face assessment visit at baseline, 3-month follow-up, and 6-month follow-up to examine treatment outcome with respect to HIV risk and substance use.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
May 6, 2010
Actual (reported)May 24, 2010
Actual (reported)December 2012
Actual (reported)May 2014
Actual (reported)stimulant use (measured via self-report and urine toxicology screening)
Participants will complete a self-report measure that assesses substance use during the past month. We will examine the total number of days that stimulants (cocaine, crack, or methamphetamine) were used during the past month. We will also conduct urine toxicology screening to determine whether participants test positive for cocaine or methamphetamine metabolites at each study visit. This is an objective measure of recent stimulant use (i.e., during the past 72 hours).
3 and 6 month follow-ups
sexual risk taking
3 and 6 month follow-ups
The Stonewall Project is an outpatient substance abuse treatment program for methamphetamine-using MSM that includes individual counseling, group counseling, and visits with a psychiatrists where indicated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
San Francisco AIDS Foundation
San Francisco, California, 94103, United States
University of California, San Francisco
San Francisco, California, 94105, United States
Adam W Carrico, Ph.D.
University of California, San Francisco
William J Woods, Ph.D.
University of California, San Francisco
Michael D. Siever, Ph.D.
San Francisco AIDS Foundation
150 participants (actual enrollment reported by the registry).
First Submitted
May 6, 2010
First Posted
May 24, 2010
Study Start
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
Evaluation of Web-Based Recovery Monitoring With Clinical Alerts
Contact the study team to confirm eligibility.
Primary Completion
December 2012
Actual (reported)Study Completion
May 2014
Actual (reported)Last Updated
October 27, 2014
Record last verified: 2014-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: